License Grant
PIT Solutions Pvt. Ltd. grants users a non-transferable, non-exclusive license to access and use MediNoteX AI solely within authorized healthcare institutions in India and the UAE. This license is strictly for professional healthcare settings, such as hospitals and clinics. Individual practitioner use is subject to future terms.
License Restrictions
  • Users shall not reverse-engineer, decompile, or disassemble the software.
  • Resale, distribution, or modification of the application without authorization is prohibited.
  • PIT Solutions Pvt. Ltd. reserves the right to audit usage to ensure compliance with license terms.
Intellectual Property Ownership
All proprietary rights within MediNoteX AI, including AI models, transcription software, and data structures, are owned by PIT Solutions Pvt. Ltd.. Users retain ownership over their respective data.
Liability and Warranty Limitations
MediNoteX AI is provided on an “as is” basis, and PIT Solutions Pvt. Ltd. is not liable for any indirect, incidental, or consequential damages resulting from the application’s use, including diagnostic accuracy or transcription outcomes.
Termination
This License Agreement remains effective until terminated. Violating any terms may result in immediate revocation of the license. Upon termination, users must cease access and use of the software and delete or return any application materials as required.
End-User Data Ownership
End-users retain ownership over patient data and other medical information, with PIT Solutions Pvt. Ltd. serving solely as a data processor.
Post-Termination Obligations
Users must delete all access credentials and cease using the application upon termination of this license.
Jurisdiction
This agreement is governed by the laws of India and the UAE. Disputes shall be resolved in the relevant jurisdiction.
Entire Agreement
This License Agreement represents the complete agreement between the user and PIT Solutions Pvt. Ltd. regarding MediNoteX AI.
Contact Information
For license-related inquiries, please contact Email Us.